Journal article
Oral hypoglycemic agents in type II diabetes mellitus
American family physician, v 52(7), pp 2075-2078
15 Nov 1995
PMID: 7484707
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Patients with type II diabetes mellitus are characterized by obesity and insulin resistance, with resultant hyperinsulinemia and hyperglycemia. Sulfonylureas are the chief therapy for patients with this type of diabetes.
Metrics
12 Record Views
Details
- Title
- Oral hypoglycemic agents in type II diabetes mellitus
- Creators
- Hanna LubbosJeffrey MillerLeslie RoseJacob L Miller - Management
- Publication Details
- American family physician, v 52(7), pp 2075-2078
- Publisher
- American Academy of Family Physicians
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Management
- Web of Science ID
- WOS:A1995TF11200012
- Scopus ID
- 2-s2.0-0028848593
- Other Identifier
- 991019184205204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Primary Health Care